Virtual Health Platform

Using the Body to Heal the Mind

Mindleap, Mydecine’s wholly-owned subsidiary, is our virtual health and wellness platform that offers a unique user experience that combines therapeutic and educational content, 1-on-1 professional support for psychedelic integration and inner wellness, and a private health journal for mental health and lifestyle monitoring. The platform is designed to support all aspects of each user’s inner wellness journey, and incorporates psychedelic education and support as a part of that broader journey.

Discover MindLeap

Artificial Intelligence & Machine Learning

Mydecine is advancing a virtual drug discovery program which uses artificial intelligence and machine learning to more rapidly screen hundreds of thousands of new molecules without the need to produce them. In partnership with the University of Alberta, Mydecine can focus on the strongest potential therapeutics for its chemical and natural development programs by simulating chemical compounds in a computer interface.

Click Here to read 3 Things Investors Should Know About Mydecine’s Artificial Intelligence & Machine Learning Drug Discovery Program